Literature DB >> 26496514

GLT1 overexpression reverses established neuropathic pain-related behavior and attenuates chronic dorsal horn neuron activation following cervical spinal cord injury.

Aditi Falnikar1, Tamara J Hala1, David J Poulsen2, Angelo C Lepore1.   

Abstract

Development of neuropathic pain occurs in a major portion of traumatic spinal cord injury (SCI) patients, resulting in debilitating and often long-term physical and psychological burdens. Following SCI, chronic dysregulation of extracellular glutamate homeostasis has been shown to play a key role in persistent central hyperexcitability of superficial dorsal horn neurons that mediate pain neurotransmission, leading to various forms of neuropathic pain. Astrocytes express the major CNS glutamate transporter, GLT1, which is responsible for the vast majority of functional glutamate uptake, particularly in the spinal cord. In our unilateral cervical contusion model of mouse SCI that is associated with ipsilateral forepaw heat hypersensitivity (a form of chronic at-level neuropathic pain-related behavior), we previously reported significant and long-lasting reductions in GLT1 expression and functional GLT1-mediated glutamate uptake in cervical spinal cord dorsal horn. To therapeutically address GLT1 dysfunction following cervical contusion SCI, we injected an adeno-associated virus type 8 (AAV8)-Gfa2 vector into the superficial dorsal horn to increase GLT1 expression selectively in astrocytes. Compared to both contusion-only animals and injured mice that received AAV8-eGFP control injection, AAV8-GLT1 delivery increased GLT1 protein expression in astrocytes of the injured cervical spinal cord dorsal horn, resulting in a significant and persistent reversal of already-established heat hypersensitivity. Furthermore, AAV8-GLT1 injection significantly reduced expression of the transcription factor and marker of persistently increased neuronal activation, ΔFosB, in superficial dorsal horn neurons. These results demonstrate that focal restoration of GLT1 expression in the superficial dorsal horn is a promising target for treating chronic neuropathic pain following SCI.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  adeno-associated virus; astrocyte; contusion; glutamate transporter; neuropathic pain

Mesh:

Substances:

Year:  2015        PMID: 26496514      PMCID: PMC4703512          DOI: 10.1002/glia.22936

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  43 in total

1.  Induction of astrocyte differentiation by propentofylline increases glutamate transporter expression in vitro: heterogeneity of the quiescent phenotype.

Authors:  Vivianne L Tawfik; Michael L Lacroix-Fralish; Kathryn K Bercury; Nancy Nutile-McMenemy; Brent T Harris; Joyce A Deleo
Journal:  Glia       Date:  2006-08-15       Impact factor: 7.452

2.  Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury.

Authors:  Angelo C Lepore; John O'Donnell; Andrew S Kim; Eun Ju Yang; Alisha Tuteja; Amanda Haidet-Phillips; Colin P O'Banion; Nicholas J Maragakis
Journal:  Glia       Date:  2011-08-31       Impact factor: 7.452

3.  Rapid changes in expression of glutamate transporters after spinal cord injury.

Authors:  Louis P Vera-Portocarrero; Charles D Mills; Zaiming Ye; Steven D Fullwood; David J McAdoo; Claire E Hulsebosch; Karin N Westlund
Journal:  Brain Res       Date:  2002-02-08       Impact factor: 3.252

Review 4.  From demyelination to remyelination: the road toward therapies for spinal cord injury.

Authors:  Florentia Papastefanaki; Rebecca Matsas
Journal:  Glia       Date:  2015-03-02       Impact factor: 7.452

Review 5.  GABA and central neuropathic pain following spinal cord injury.

Authors:  Young S Gwak; Claire E Hulsebosch
Journal:  Neuropharmacology       Date:  2011-01-07       Impact factor: 5.250

Review 6.  Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury.

Authors:  Young Seob Gwak; Claire E Hulsebosch
Journal:  Curr Pain Headache Rep       Date:  2011-06

7.  Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI.

Authors:  Ke Li; Elham Javed; Tamara J Hala; Daniel Sannie; Kathleen A Regan; Nicholas J Maragakis; Megan C Wright; David J Poulsen; Angelo C Lepore
Journal:  Mol Ther       Date:  2014-12-10       Impact factor: 11.454

8.  Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat.

Authors:  Young Seob Gwak; Eric D Crown; Geda C Unabia; Claire E Hulsebosch
Journal:  Pain       Date:  2008-03-18       Impact factor: 6.961

9.  Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury.

Authors:  Susan M Carlton; Junhui Du; Huai Yu Tan; Olivera Nesic; Gregory L Hargett; Anne C Bopp; Ammar Yamani; Qing Lin; William D Willis; Claire E Hulsebosch
Journal:  Pain       Date:  2009-10-22       Impact factor: 6.961

Review 10.  Mechanisms of chronic central neuropathic pain after spinal cord injury.

Authors:  Claire E Hulsebosch; Bryan C Hains; Eric D Crown; Susan M Carlton
Journal:  Brain Res Rev       Date:  2008-12-25
View more
  15 in total

Review 1.  Neuropathic Pain After Spinal Cord Injury: Challenges and Research Perspectives.

Authors:  Rani Shiao; Corinne A Lee-Kubli
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 2.  Improving the therapeutic efficacy of neural progenitor cell transplantation following spinal cord injury.

Authors:  Michael A Lane; Angelo C Lepore; Itzhak Fischer
Journal:  Expert Rev Neurother       Date:  2016-12-21       Impact factor: 4.618

3.  MAP7 Regulates Axon Collateral Branch Development in Dorsal Root Ganglion Neurons.

Authors:  Stephen R Tymanskyj; Benjamin Yang; Aditi Falnikar; Angelo C Lepore; Le Ma
Journal:  J Neurosci       Date:  2017-01-09       Impact factor: 6.167

Review 4.  Astrocytes in chronic pain and itch.

Authors:  Ru-Rong Ji; Christopher R Donnelly; Maiken Nedergaard
Journal:  Nat Rev Neurosci       Date:  2019-09-19       Impact factor: 34.870

5.  Impaired sensitivity to pain stimuli in plasma membrane calcium ATPase 2 (PMCA2) heterozygous mice: a possible modality- and sex-specific role for PMCA2 in nociception.

Authors:  Veronika Khariv; Li Ni; Ayomi Ratnayake; Sujitha Sampath; Brianna M Lutz; Xuan-Xiang Tao; Robert F Heary; Stella Elkabes
Journal:  FASEB J       Date:  2016-10-04       Impact factor: 5.191

Review 6.  How is chronic pain related to sympathetic dysfunction and autonomic dysreflexia following spinal cord injury?

Authors:  Edgar T Walters
Journal:  Auton Neurosci       Date:  2017-01-27       Impact factor: 3.145

7.  The Effect of Electrospun Fiber Diameter on Astrocyte-Mediated Neurite Guidance and Protection.

Authors:  Christopher D L Johnson; Jonathan M Zuidema; Kathryn R Kearns; Alianna B Maguire; Gregory P Desmond; Deanna M Thompson; Ryan J Gilbert
Journal:  ACS Appl Bio Mater       Date:  2018-12-04

8.  Cervical spinal cord injury-induced neuropathic pain in male mice is associated with a persistent pro-inflammatory macrophage/microglial response in the superficial dorsal horn.

Authors:  Eric V Brown; Aditi Falnikar; Nicolette Heinsinger; Lan Cheng; Carrie E Andrews; Michael DeMarco; Angelo C Lepore
Journal:  Exp Neurol       Date:  2021-05-12       Impact factor: 5.620

9.  Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice.

Authors:  Rihua Wang; Xue Zhao; Jin Xu; Yifan Wen; Aiping Li; Ming Lu; Jianwei Zhou
Journal:  Cell Death Dis       Date:  2018-03-02       Impact factor: 8.469

10.  Estrous cycle influences excitatory amino acid transport and visceral pain sensitivity in the rat: effects of early-life stress.

Authors:  Rachel D Moloney; Jahangir Sajjad; Tara Foley; Valeria D Felice; Timothy G Dinan; John F Cryan; Siobhain M O'Mahony
Journal:  Biol Sex Differ       Date:  2016-07-14       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.